GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro (Q39753573)

14 September 2017

title

GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro (English)

1 reference

14 September 2017

1 reference

2

0 references

Irving Vidaurre

series ordinal

5

object named as

Irving Vidaurre

1 reference

14 September 2017

1

Szabolcs Bellyei

1 reference

14 September 2017

Marta Zarandi

3

1 reference

14 September 2017

Jozsef L Varga

series ordinal

4

1 reference

14 September 2017

Eva Pozsgai

series ordinal

6

1 reference

14 September 2017

language of work or name

English

0 references

publication date

12 January 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

293

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

31-40

1 reference

Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene

14 September 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Peptide analogs in the therapy of prostate cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Invasion and metastasis markers in cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Intercellular adhesion, signalling and the cytoskeleton

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth hormone-releasing hormone in oncology

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

beta-catenin signaling and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Hypothalamic hormones and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

LH-RH analogues: I. Their impact on reproductive medicine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

GnRH analogs reduce invasiveness of human breast cancer cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

The metastatic cascade in prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Cancer statistics, 2008

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Inhibition of cell death by a novel 16.2 kD heat shock protein predominantly via Hsp90 mediated lipid rafts stabilization and Akt activation pathway.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Antagonism of endogenous growth hormone-releasing hormone (GHRH) leads to reduced proliferation and apoptosis in MDA231 breast cancer cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2009.12.014

Identifiers

DOI

10.1016/J.CANLET.2009.12.014

1 reference

14 September 2017

1 reference